Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trialGuy Thwaites, Elian Liu, Janet Cairns et al.|The Lancet|2017Cited by 186
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trialMark T. Drayson, Janet Dunn, Stella Bowcock et al.|The Lancet Oncology|2019Cited by 160
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trialGuy Thwaites, A. Sarah Walker, Cressida Auckland et al.|Trials|2012Cited by 27
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCTGuy Thwaites, A. Sarah Walker, Matthew Scarborough et al.|Health Technology Assessment|2018Cited by 15
Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trialCatherine Atkin, Gulnaz Iqbal, Tim Planche et al.|British Journal of Haematology|2020Cited by 9